Knockdown of Translocator Protein (TSPO) Slows AKI to CKD Transition through Regulating Mitochondrial Dysfunction

Background: Acute kidney injury (AKI) has been widely recognized as an important risk factor for the occurrence and development of chronic kidney disease (CKD). Emerging studies suggest that mitochondrial dysfunction is a pivotal contributor to the transition from AKI to CKD. Translocator protein (TSPO), located on the outer mitochondrial membrane, is associated with kidney tubular cell death and regeneration in AKI. However, the role of TSPO in AKI to CKD transition remains unknown. Methods: Kidney tubule-specific TSPO knockout (Tubule-TSPO-/-) mice were created by crossing TSPO floxed (TSPOflox/flox) mice on a C57BL/6J background with tamoxifen inducible Ksp-CreERT2 mice. Unilateral ischemia-reperfusion injury (uIRI) for different timepoints was performed on both Tubule-TSPO-/- and TSPOflox/flox wildtype mice to establish AKI to CKD transition. Kidneys were harvested for histology, inflammation, fibrosis and mitochondrial function measurements. Results: Both TSPO mRNA and protein levels were increased at day 1 and lasted for at least 14 days after uIRI. Histopathologically, uIRI-induced tubular damage was reversed by knockdown of TSPO at day 7 and day 14. Induction of fibronectin, Col-1, TNF-α, CCL-2 and IL-1β mRNA in the uIRI kidney was reduced in knockout mice compared to control. In 14 day-uIRI mice, immunohistochemical analysis further confirmed significant reduction of Col-1 and Col-3 expression by TSPO depletion. Furthermore, PGC1-α, the master regulator of mitochondrial function, was significantly increased after knockdown of TSPO. Electron microscopy demonstrated a higher number of mitochondria and improved mitochondrial morphology with TSPO depletion. Reduction of mitochondrial DNA copy number by uIRI was also reversed by knockdown of TSPO. Conclusion: Knockdown of TSPO in tubular cells could alleviate kidney inflammation and fibrosis in murine uIRI models, increase mitochondrial number and restore mitochondrial structure. The results suggested that TSPO could play an important role in regulating mitochondrial function during AKI to CKD transition progress. Funding: Health and Medical Research Fund (HMRF) of Hong Kong (grant no. 09202356); Hong Kong Society of Nephrology Research Grant 2022

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024zvz7ggag
Primary Topic
Acute Kidney Injury Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Knockdown of Translocator Protein (TSPO) Slows AKI to CKD Transition through Regulating Mitochondrial Dysfunction

Kar Neng Lai, Wai Han Yiu, Jingyuan Ma, Sydney C.W. Tang et al.
Journal of the American Society of Nephrology
Acute Kidney Injury Research
article

Knockdown of Translocator Protein (TSPO) Slows AKI to CKD Transition through Regulating Mitochondrial Dysfunction

Kar Neng Lai, Wai Han Yiu, Jingyuan Ma, Sydney C.W. Tang, Yuchen Feng
article en

Abstract

Background: Acute kidney injury (AKI) has been widely recognized as an important risk factor for the occurrence and development of chronic kidney disease (CKD). Emerging studies suggest that mitochondrial dysfunction is a pivotal contributor to the transition from AKI to CKD. Translocator protein (TSPO), located on the outer mitochondrial membrane, is associated with kidney tubular cell death and regeneration in AKI. However, the role of TSPO in AKI to CKD transition remains unknown. Methods: Kidney tubule-specific TSPO knockout (Tubule-TSPO-/-) mice were created by crossing TSPO floxed (TSPOflox/flox) mice on a C57BL/6J background with tamoxifen inducible Ksp-CreERT2 mice. Unilateral ischemia-reperfusion injury (uIRI) for different timepoints was performed on both Tubule-TSPO-/- and TSPOflox/flox wildtype mice to establish AKI to CKD transition. Kidneys were harvested for histology, inflammation, fibrosis and mitochondrial function measurements. Results: Both TSPO mRNA and protein levels were increased at day 1 and lasted for at least 14 days after uIRI. Histopathologically, uIRI-induced tubular damage was reversed by knockdown of TSPO at day 7 and day 14. Induction of fibronectin, Col-1, TNF-α, CCL-2 and IL-1β mRNA in the uIRI kidney was reduced in knockout mice compared to control. In 14 day-uIRI mice, immunohistochemical analysis further confirmed significant reduction of Col-1 and Col-3 expression by TSPO depletion. Furthermore, PGC1-α, the master regulator of mitochondrial function, was significantly increased after knockdown of TSPO. Electron microscopy demonstrated a higher number of mitochondria and improved mitochondrial morphology with TSPO depletion. Reduction of mitochondrial DNA copy number by uIRI was also reversed by knockdown of TSPO. Conclusion: Knockdown of TSPO in tubular cells could alleviate kidney inflammation and fibrosis in murine uIRI models, increase mitochondrial number and restore mitochondrial structure. The results suggested that TSPO could play an important role in regulating mitochondrial function during AKI to CKD transition progress. Funding: Health and Medical Research Fund (HMRF) of Hong Kong (grant no. 09202356); Hong Kong Society of Nephrology Research Grant 2022

Journal of the American Society of NephrologyVol. 35(10S)
University of Hong Kong (HK)
Zero hunger
Openalex Percentile: Top 72%
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.